|
LUC7L3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7488000000343E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.243750E-04 |
| Normal-vs-Stage2 |
8.12919999981787E-07 |
| Normal-vs-Stage3 |
2.46859999109006E-09 |
| Normal-vs-Stage4 |
5.102100E-03 |
| Stage1-vs-Stage2 |
8.555700E-02 |
| Stage1-vs-Stage3 |
4.457300E-03 |
| Stage1-vs-Stage4 |
6.882000E-01 |
| Stage2-vs-Stage3 |
7.037000E-01 |
| Stage2-vs-Stage4 |
4.281200E-01 |
| Stage3-vs-Stage4 |
2.673200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.86759999979358E-07 |
| Normal-vs-AfricanAmerican |
8.38780000000927E-05 |
| Normal-vs-Asian |
1.594150E-02 |
| Caucasian-vs-AfricanAmerican |
3.956400E-01 |
| Caucasian-vs-Asian |
1.432380E-01 |
| AfricanAmerican-vs-Asian |
6.571900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.435600E-04 |
| Normal-vs-Female |
2.31130000027946E-07 |
| Male-vs-Female |
2.382600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.359130E-04 |
| Normal-vs-Age(41-60Yrs) |
2.68290000005056E-06 |
| Normal-vs-Age(61-80Yrs) |
1.52300000000327E-06 |
| Normal-vs-Age(81-100Yrs) |
3.010600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.615400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.007600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.179830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.076000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.950050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.390000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.62329999734368E-08 |
| Classical-VS-Follicular |
5.666600E-01 |
| Classical-VS-Other |
7.963000E-01 |
| Classical-VS-Normal |
1.209150E-04 |
| Tall-VS-Follicular |
9.64110000000185E-05 |
| Tall-VS-Other |
2.677900E-03 |
| Tall-VS-Normal |
1.74371628247627E-12 |
| Follicular-VS-Other |
6.708000E-01 |
| Follicular-VS-Normal |
2.563000E-04 |
| Other-VS-Normal |
1.488160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.40560000048285E-07 |
| Normal-vs-N1 |
1.796610E-01 |
| N0-vs-N1 |
6.657900E-02 |
|
|
